http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101007541-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
filingDate | 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101007541-B1 |
titleOfInvention | Pharmaceutical composition for the treatment of liver disease |
abstract | The present invention relates to a pharmaceutical composition for inhibiting the development of liver disease by detoxifying various harmful substances that adversely affect the liver of the human body, and more particularly, comprising a jinjin extract, barberry extract and a pharmaceutically acceptable carrier. It is possible to protect the liver by reducing the activity of the harmful substances by effectively inhibiting the transfer of various harmful substances adversely affecting the liver to free radicals by the synergistic action of the extracts of jinjin and Bran lotus, which are active ingredients. It provides a pharmaceutical composition for treating liver disease.n n n n Phosphorus, Bacterium, Liver Disease, Pharmaceutical, Free Group, Mixed Composition |
priorityDate | 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.